ArticleThe American journal of case reports2024
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments.
Flavia Sanmartin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.